It is no secret that reprints of studies published in medical journals are widely used as promotional tools by the pharmaceutical industry. And these reprints are also a welcome source of revenue for publishers. Of course, this has raised perennial questions about conflicts of interest, since the...
FULL ARTICLE AT Pharmalot